Inflammation, Adipose Tissue, and T Cells:
What Is the "Straight Skinny" on Lean Versus Fat Mice?
To the Editor: Obesity is associated with chronic inflammation in adipose tissue (AT), as evidenced by increased levels of cytokines/chemokines and accumulation and activation of macrophages and T cells, 1-3 which are acknowledged as important contributors to insulin resistance in obesity. Recently, using Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice, Sultan et al reported that T cell-mediated inflammation does not cause insulin resistance in lean mice. 4 Compared to controls (Apoe Ϫ/Ϫ mice), lean Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice showed increased inflammation in AT (but not specifically in AT), as indicated by increased content of T cells and macrophages, higher levels of tumor necrosis factor-␣, interferon-␥, and monocyte chemoattractant protein-1, but a comparable level of interleukin (IL)-6. 4 However, lean Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice did not show worsened insulin resistance compared to Apoe Ϫ/Ϫ mice. 4 Therefore, the authors concluded that T cell-mediated inflammation in AT does not cause insulin resistance in hyperlipidemic mice. 4 We acknowledge Sultan et al for their report on the study of the role of T cell-mediated inflammation in insulin resistance. 4 However, because of the following limitations of this study, we feel that it is too early to make any firm conclusions on the potential role of T cell-mediated AT inflammation in metabolic dysfunctions, particularly with diet-induced obesity, which is commonly accompanied by dyslipidemia.
First, Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice displayed a unique inflammation pattern in AT, with unchanged IL-6 level compared to Apoe Ϫ/Ϫ controls but lower IL-6 level than B6 mice. 4 However, obese mice show increased IL-6 level compared to leans. Thus, this mouse model does not represent the AT inflammation pattern observed in obesity and therefore may have little if any relevance to the T cell-mediated AT inflammation in obesity. The pathophysiology of the lipid disorders associated with insulin resistance and obesity, particularly as related to fatty acid metabolism, is markedly different than the Apoe Ϫ/Ϫ model. Second, the authors used lean mice. 4 When we and others study the role of chronic AT inflammation in insulin resistance, we mostly refer to obese conditions and examine the contribution of obesity-related inflammation to metabolic dysfunctions. Results obtained in lean mice in a study of the role of inflammation per se in insulin resistance may have little direct relevance to obese conditions. Third, this study used female mice. 4 Most previous studies of obesity-related inflammation used male mice. 1,5,6 As we showed previously, 2 female mice were less predisposed to develop insulin resistance than male mice with obesity, even though they were maintained on the same type of high-fat diet for the same period of time. Therefore, it is unclear whether a sex effect existed in this study. 4 Fourth, in addition to T cells, macrophages were also increased and activated in AT of Apoe Ϫ/Ϫ ϫCD4dnTGFbR. The absence of impaired insulin sensitivity in Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice was also in conflict with a role of macrophage-mediated AT inflamma-tion in insulin resistance, as previously demonstrated by several research laboratories. 5, 6 Fifth, the authors provided some evidence indicating that the lack of IL-6 upregulation may contribute to the absence of insulin resistance in Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice. 4 They also suggested that upregulation of 11␤-HSD1 in AT of Apoe Ϫ/Ϫ ϫCD4dnTGFbR (compared to Apoe Ϫ/Ϫ ) mice contributed to the lack of IL-6 upregulation in this mouse model. However, they did not show a significant difference between Apoe Ϫ/Ϫ ϫCD4dnTGFbR and Apoe Ϫ/Ϫ in AT IL-6 levels. Both Apoe Ϫ/Ϫ ϫCD4dnTGFbR and Apoe Ϫ/Ϫ mice had lower IL-6 levels in AT than B6. The authors might assume that the increased 11␤-HSD1, which catalyzes generation of cortisol, in AT of Apoe Ϫ/Ϫ ϫCD4dnTGFbR may have counterbalanced the effect of the increased cytokines (tumor necrosis factor-␣, monocyte chemoattractant protein-1, etc) on IL-6 regulation in Apoe Ϫ/Ϫ ϫCD4dnTGFbR because these cytokines were low in AT of Apoe Ϫ/Ϫ mice. However, the low levels of cytokines (including IL-6) in AT of Apoe Ϫ/Ϫ mice as compared to B6 were accompanied by insulin resistance, as the authors observed in Apoe Ϫ/Ϫ mice, 4 which does not support a key role of IL-6 in insulin resistance. 4 In summary, Sultan et al reported some novel phenotypic changes of lean Apoe Ϫ/Ϫ ϫCD4dnTGFbR mice in AT and metabolic functions, which are caused by loss of TGF-␤dependent inhibition of T-cell activation. 4 However, because of the limitations of this study, the potential contribution of T cell-mediated AT inflammation to insulin resistance with dietinduced obesity, which is the major mechanism driving this problem in humans, clearly requires additional study.
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